TrialClinical and translational science2022

Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis.

Candice Jamois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.